mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
8e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0009 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |